SEC Form 4 · accession 0001325812-15-000018
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
David T Howton
Officer — SVP, General Counsel
Period of report
Feb 27, 2015
Accepted (ET)
Mar 3, 2015 · 6:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $13.90 | Feb 27, 2015 | A | 9,603 | A | — | Feb 27, 2025 | Common Stock | 9,603 | 9,603 | D |
| Non-Qualified Stock Option (right to buy)F1 | $13.90 | Feb 27, 2015 | A | 76,397 | A | — | Feb 27, 2025 | Common Stock | 76,397 | 76,397 | D |
Explanation of responses
- F125% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant.